NCT02344498Active, not recruiting
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa
Source: ClinicalTrials.gov · Last updated 15 Nov 2024
Brief summary (registry, in English)
Viral hepatitis kills nearly one million people each year, even though effective treatment exists. The aim of this study is to establish a treatment protocol for hepatitis B, which is simple and cheap enough to be implemented in resource-limited settings.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 7350 (actual)
- First submitted
- 16 Jan 2015
- Start date
- Jan 2015
- Primary completion date
- Dec 2026
- Lead sponsor
- Oslo University Hospital
- Diseases
- Hepatitis B
- NCT number
- NCT02344498
What you commit to
- Study type: Observational
- Participants enrolled: 7350
- From Jan 2015 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Children \<18 years, other terminal disease (cancer etc.)
Who the study is looking for
- Consenting adults (≥18 years) residing in Ethiopia who are HBsAg positive
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St Paul Hospital Millennium Medical College Coordinator of this site? Confirm its status | Addis Ababa | Ethiopia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.